热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措

路透中文

May 05

热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措

5月5日 -

** Embecta Corp &EMBC.O> 股价盘前下跌26%，至6.84美元

** 受影响美国业务的市场动态及即将完成的Owen Mumford收购案影响，这家医疗器械制造商下调了年度业绩预期 (link)

** 预计2026年营收为10.2亿至10.4亿美元，此前预测为10.7亿至10.9亿美元

** 预计调整后每股收益为1.55美元至1.75美元，低于此前2.80美元至3.00美元的区间

** 第二季度营收2.218亿美元，未达2.3557亿美元的预期；据伦敦证券交易所集团（LSEG）数据显示，经调整后每股收益27美分，低于42美分的预期

** 首席执行官库尔迪卡尔（Devdatt Kurdikar）表示，下调后的展望基于以下假设：影响第二季度美国业务的动态将在今年剩余时间内持续

** 他补充说，公司已启动对成本结构和组织架构的审查，并表示将在该流程完成后向投资者通报审查结果及随之采取的任何措施

** 股票今年以来累计下跌22%

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2633091712"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2633091712\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2633091712?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-05-05 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633091712","market":"us","top_or_hot":-1,"title":"热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措</title></head><body><p>\n<span>5月5日</span><span> - </span>\n</p><p>** Embecta Corp &amp;EMBC.O&gt; 股价盘前下跌26%，至6.84美元</p><p>** 受影响美国业务的市场动态及即将完成的Owen Mumford收购案影响，这家医疗器械制造商下调了年度业绩预期 (<span>link</span>) </p><p>** 预计2026年营收为10.2亿至10.4亿美元，此前预测为10.7亿至10.9亿美元</p><p>** 预计调整后每股收益为1.55美元至1.75美元，低于此前2.80美元至3.00美元的区间</p><p>** 第二季度营收2.218亿美元，未达2.3557亿美元的预期；据<a href=\"https://laohu8.com/S/LSE.UK\">伦敦证券交易所</a>集团（LSEG）数据显示，<span>经调整后</span>每股<span>收益</span>27美分，低于42美分的预期</p><p>** 首席执行官库尔迪卡尔（Devdatt Kurdikar）表示，下调后的展望基于以下假设：影响第二季度美国业务的动态将在今年剩余时间内持续</p><p>** 他补充说，公司已启动对成本结构和组织架构的审查，并表示将在该流程完成后向投资者通报审查结果及随之采取的任何措施</p><p>** 股票今年以来累计下跌22%</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-05-05 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措</title></head><body><p>\n<span>5月5日</span><span> - </span>\n</p><p>** Embecta Corp &amp;EMBC.O&gt; 股价盘前下跌26%，至6.84美元</p><p>** 受影响美国业务的市场动态及即将完成的Owen Mumford收购案影响，这家医疗器械制造商下调了年度业绩预期 (<span>link</span>) </p><p>** 预计2026年营收为10.2亿至10.4亿美元，此前预测为10.7亿至10.9亿美元</p><p>** 预计调整后每股收益为1.55美元至1.75美元，低于此前2.80美元至3.00美元的区间</p><p>** 第二季度营收2.218亿美元，未达2.3557亿美元的预期；据<a href=\"https://laohu8.com/S/LSE.UK\">伦敦证券交易所</a>集团（LSEG）数据显示，<span>经调整后</span>每股<span>收益</span>27美分，低于42美分的预期</p><p>** 首席执行官库尔迪卡尔（Devdatt Kurdikar）表示，下调后的展望基于以下假设：影响第二季度美国业务的动态将在今年剩余时间内持续</p><p>** 他补充说，公司已启动对成本结构和组织架构的审查，并表示将在该流程完成后向投资者通报审查结果及随之采取的任何措施</p><p>** 股票今年以来累计下跌22%</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EMBC","symbol_name":"Embecta Corp.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL4S41I0YO:1","article_id":"2633091712","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2633091712","pubTimestamp":1777981450,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"EMBC":"Embecta Corp.","BK4198":"医疗保健用品"},"translate_title":"Hot Topics-Embecta shares fall as it lowers performance estimates and reassesses business moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMBC":0.9},"content_text":"热门话题-Embecta股价下跌，因下调业绩预期并重新评估业务举措\n5月5日 - \n** Embecta Corp &EMBC.O> 股价盘前下跌26%，至6.84美元** 受影响美国业务的市场动态及即将完成的Owen Mumford收购案影响，这家医疗器械制造商下调了年度业绩预期 (link) ** 预计2026年营收为10.2亿至10.4亿美元，此前预测为10.7亿至10.9亿美元** 预计调整后每股收益为1.55美元至1.75美元，低于此前2.80美元至3.00美元的区间** 第二季度营收2.218亿美元，未达2.3557亿美元的预期；据伦敦证券交易所集团（LSEG）数据显示，经调整后每股收益27美分，低于42美分的预期** 首席执行官库尔迪卡尔（Devdatt Kurdikar）表示，下调后的展望基于以下假设：影响第二季度美国业务的动态将在今年剩余时间内持续** 他补充说，公司已启动对成本结构和组织架构的审查，并表示将在该流程完成后向投资者通报审查结果及随之采取的任何措施** 股票今年以来累计下跌22%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}